Variant report

Variant	esv3373211
Chromosome Location	chr2:30368973-30372021
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:889)
CpG islands
(count:976)
Chromatin interactive
region (count:13)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:889 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:30370782-30370881	HepG2	liver:	n/a	n/a
2	ARID3A	chr2:30369229-30369901	HepG2	liver:	n/a	n/a
3	ARID3A	chr2:30369311-30369561	K562	blood:	n/a	n/a
4	ATF1	chr2:30369217-30369838	K562	blood:	n/a	n/a
5	ATF2	chr2:30369062-30369768	GM12878	blood:	n/a	n/a
6	ATF3	chr2:30370687-30370877	GM12878	blood:	n/a	n/a
7	ATF3	chr2:30370101-30370496	K562	blood:	n/a	n/a
8	ATF3	chr2:30370468-30371040	HepG2	liver:	n/a	n/a
9	ATF3	chr2:30370606-30370963	H1-hESC	embryonic stem cell:	n/a	n/a
10	ATF3	chr2:30370597-30370911	K562	blood:	n/a	n/a
11	ATF3	chr2:30370550-30370998	GM12878	blood:	n/a	n/a
12	ATF3	chr2:30369225-30369638	K562	blood:	n/a	n/a
13	ATF3	chr2:30370564-30370934	HepG2	liver:	n/a	n/a
14	BACH1	chr2:30369276-30369591	K562	blood:	n/a	n/a
15	BACH1	chr2:30370897-30370911	H1-hESC	embryonic stem cell:	n/a	n/a
16	BACH1	chr2:30369262-30370104	H1-hESC	embryonic stem cell:	n/a	n/a
17	BATF	chr2:30371777-30372055	GM12878	blood:	n/a	chr2:30372041-30372050
18	BCL3	chr2:30369165-30369994	A549	lung:	n/a	chr2:30369767-30369776
19	BCL3	chr2:30369050-30370121	A549	lung:	n/a	chr2:30369767-30369776 chr2:30370037-30370046
20	BHLHE40	chr2:30369171-30369890	HepG2	liver:	n/a	n/a
21	BHLHE40	chr2:30369115-30369593	HepG2	liver:	n/a	n/a
22	BHLHE40	chr2:30368861-30369864	GM12878	blood:	n/a	n/a
23	BHLHE40	chr2:30370597-30370942	K562	blood:	n/a	n/a
24	BHLHE40	chr2:30369220-30369655	A549	lung:	n/a	n/a
25	BHLHE40	chr2:30368862-30370056	K562	blood:	n/a	n/a
26	BHLHE40	chr2:30370489-30370988	GM12878	blood:	n/a	n/a
27	BRCA1	chr2:30369209-30369693	Hela-S3	cervix:	n/a	n/a
28	BRCA1	chr2:30369134-30369544	HepG2	liver:	n/a	n/a
29	BRCA1	chr2:30371560-30372091	Hela-S3	cervix:	n/a	n/a
30	CBX3	chr2:30369178-30369911	K562	blood:	n/a	n/a
31	CCNT2	chr2:30369080-30371315	K562	blood:	n/a	chr2:30369709-30369718 chr2:30369566-30369575 chr2:30369670-30369679
32	CEBPB	chr2:30369264-30369881	MCF-7	breast:	n/a	chr2:30369534-30369542
33	CEBPB	chr2:30371768-30372133	IMR90	lung:	n/a	chr2:30371940-30371951
34	CEBPB	chr2:30369184-30369778	K562	blood:	n/a	chr2:30369534-30369542
35	CEBPB	chr2:30369338-30369756	H1-hESC	embryonic stem cell:	n/a	chr2:30369534-30369542
36	CEBPB	chr2:30369097-30370032	HCT-116	colon:	n/a	chr2:30369534-30369542
37	CEBPB	chr2:30368979-30369897	A549	lung:	n/a	chr2:30369534-30369542
38	CEBPB	chr2:30369325-30369716	K562	blood:	n/a	chr2:30369534-30369542
39	CEBPB	chr2:30371754-30372818	Hela-S3	cervix:	n/a	chr2:30371940-30371951
40	CEBPB	chr2:30371742-30372802	K562	blood:	n/a	chr2:30371940-30371951
41	CEBPB	chr2:30371764-30372135	HepG2	liver:	n/a	chr2:30371940-30371951
42	CEBPB	chr2:30369173-30369861	IMR90	lung:	n/a	chr2:30369534-30369542
43	CEBPB	chr2:30371759-30372089	K562	blood:	n/a	chr2:30371940-30371951
44	CEBPB	chr2:30369197-30369838	MCF-7	breast:	n/a	chr2:30369534-30369542
45	CEBPB	chr2:30369084-30369888	A549	lung:	n/a	chr2:30369534-30369542
46	CEBPB	chr2:30371725-30372215	A549	lung:	n/a	chr2:30371940-30371951
47	CEBPB	chr2:30371725-30372802	H1-hESC	embryonic stem cell:	n/a	chr2:30371940-30371951
48	CEBPB	chr2:30368923-30369848	HepG2	liver:	n/a	chr2:30369534-30369542
49	CEBPB	chr2:30369445-30369700	HepG2	liver:	n/a	chr2:30369534-30369542
50	CEBPB	chr2:30369300-30369770	K562	blood:	n/a	chr2:30369534-30369542

(count:976 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:30370629-30370679	HCF	heart:	n/a
2	chr2:30369314-30369364	GM12891	blood:	n/a
3	chr2:30371369-30371419	PrEC	prostate:	n/a
4	chr2:30369455-30369505	HAEpiC	amniotic membrane:	n/a
5	chr2:30369896-30369946	ProgFib	skin:	n/a
6	chr2:30369763-30369813	HRCEpiC	kidney:	n/a
7	chr2:30369779-30369829	HPAEpiC	pulmonary alveolar:	n/a
8	chr2:30369105-30369155	RPTEC	kidney:	n/a
9	chr2:30369779-30369829	RPTEC	kidney:	n/a
10	chr2:30370632-30370682	HCT-116	colon:	n/a
11	chr2:30369576-30369626	BJ	skin:	n/a
12	chr2:30369896-30369946	SAEC	small airway:	n/a
13	chr2:30369455-30369505	SK-N-SH_RA	brain:	n/a
14	chr2:30370168-30370218	MCF-7	breast:	n/a
15	chr2:30371990-30372040	HCF	heart:	n/a
16	chr2:30369896-30369946	NHDF-neo	bronchial:	n/a
17	chr2:30369576-30369626	ECC-1	luminal epithelium:	n/a
18	chr2:30369896-30369946	Hela-S3	cervix:	n/a
19	chr2:30370168-30370218	HRPEpiC	eye:	n/a
20	chr2:30369105-30369155	GM06990	blood:	n/a
21	chr2:30369571-30369621	AG09309	skin:	n/a
22	chr2:30369571-30369621	HEEpiC	esophagus:	n/a
23	chr2:30369584-30369634	IMR90	lung:	fetal
24	chr2:30369455-30369505	Caco-2	colon:	n/a
25	chr2:30371369-30371419	Caco-2	colon:	n/a
26	chr2:30369576-30369626	AG09309	skin:	n/a
27	chr2:30370168-30370218	HUVEC	blood vessel:	n/a
28	chr2:30369763-30369813	NB4	blood:	n/a
29	chr2:30369584-30369634	AG09319	gingival:	n/a
30	chr2:30370168-30370218	NB4	blood:	n/a
31	chr2:30369455-30369505	SK-N-MC	brain:	n/a
32	chr2:30369584-30369634	AG10803	skin:	n/a
33	chr2:30371369-30371419	SK-N-MC	brain:	n/a
34	chr2:30369584-30369634	SK-N-MC	brain:	n/a
35	chr2:30369576-30369626	PANC-1	pancreas:	n/a
36	chr2:30369584-30369634	HRCEpiC	kidney:	n/a
37	chr2:30370632-30370682	IMR90	lung:	fetal
38	chr2:30369571-30369621	HNPCEpiC	eye:	n/a
39	chr2:30369571-30369621	IMR90	lung:	fetal
40	chr2:30369571-30369621	HRE	kidney:	n/a
41	chr2:30369576-30369626	AG09319	gingival:	n/a
42	chr2:30369382-30369432	SK-N-MC	brain:	n/a
43	chr2:30369105-30369155	HepG2	liver:	n/a
44	chr2:30369455-30369505	RPTEC	kidney:	n/a
45	chr2:30369576-30369626	HEEpiC	esophagus:	n/a
46	chr2:30369314-30369364	HRE	kidney:	n/a
47	chr2:30369571-30369621	Hela-S3	cervix:	n/a
48	chr2:30369571-30369621	H1-hESC	embryonic stem cell:	embryo
49	chr2:30370168-30370218	PFSK-1	brain:	n/a
50	chr2:30369314-30369364	SK-N-MC	brain:	n/a

(count:13 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:30361445..30366413-chr2:30367443..30370864,6	MCF-7	breast:
2	chr2:30337518..30339089-chr2:30368226..30369771,2	K562	blood:
3	chr2:30363131..30365100-chr2:30367257..30368991,2	K562	blood:
4	chr2:30369470..30372362-chr2:30669050..30670728,2	MCF-7	breast:
5	chr2:30366474..30375732-chr2:30375765..30384167,14	MCF-7	breast:
6	chr2:30368663..30370783-chr2:30453321..30456156,2	K562	blood:
7	chr2:30371465..30373484-chr2:30397910..30400292,3	K562	blood:
8	chr2:30361415..30365100-chr2:30365958..30368991,4	K562	blood:
9	chr2:30370673..30372393-chr2:30454162..30455838,3	K562	blood:
10	chr2:30370893..30374119-chr2:30453845..30456707,3	K562	blood:
11	chr2:30362220..30364424-chr2:30369262..30372123,2	K562	blood:
12	chr2:30369876..30376242-chr2:30376921..30381158,8	K562	blood:
13	chr2:30357579..30360858-chr2:30368602..30370618,3	MCF-7	breast:

No data

Variant related genes	Relation type
YPEL5	TF binding region
ENSG00000233862	TF binding region
YPEL5	CpG island
ENSG00000233862	CpG island
ENSG00000213626	chromatin interactions
ENSG00000172954	chromatin interactions
ENSG00000233862	chromatin interactions
ENSG00000119801	chromatin interactions

Extended variants
information (count: 106 )
Associated
traits (count: 66 )

Variant overlapped rSNPs/rCNVs (count:106 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs190619039	chr2:30369021-30369022	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs556847985	chr2:30369034-30369035	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs181725670	chr2:30369119-30369120	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs142698164	chr2:30369230-30369231	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
5	rs553363654	chr2:30369244-30369245	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs372644022	chr2:30369273-30369274	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs147367468	chr2:30369288-30369289	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs374349402	chr2:30369356-30369357	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs562136364	chr2:30369361-30369362	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs114004281	chr2:30369362-30369363	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs544774699	chr2:30369377-30369378	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs564660470	chr2:30369385-30369386	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs533728988	chr2:30369399-30369400	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs572440112	chr2:30369403-30369404	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs148426211	chr2:30369415-30369416	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs559331599	chr2:30369417-30369418	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs376077071	chr2:30369446-30369447	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs528039159	chr2:30369469-30369470	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs547901791	chr2:30369473-30369474	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs186112377	chr2:30369516-30369517	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
21	rs530514867	chr2:30369579-30369580	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs550411132	chr2:30369612-30369613	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
23	rs371307615	chr2:30369617-30369618	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
24	rs570535896	chr2:30369645-30369646	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs2276548	chr2:30369660-30369661	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs545160040	chr2:30369663-30369664	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
27	rs552958288	chr2:30369687-30369688	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
28	rs566880616	chr2:30369699-30369700	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
29	rs35039108	chr2:30369702-30369703	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
30	rs12470512	chr2:30369708-30369709	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs555906032	chr2:30369766-30369767	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
32	rs372367909	chr2:30369805-30369806	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs11689346	chr2:30369808-30369809	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs139589300	chr2:30369815-30369816	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs558358385	chr2:30369831-30369832	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs560680038	chr2:30369844-30369845	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs578096211	chr2:30369851-30369852	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs540933565	chr2:30369854-30369855	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs560593063	chr2:30369896-30369897	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs565437766	chr2:30369911-30369912	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs374099750	chr2:30370091-30370092	Weak transcription Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs528077456	chr2:30370135-30370136	Weak transcription Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs541467574	chr2:30370151-30370152	Weak transcription Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs561345406	chr2:30370233-30370234	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
45	rs530549862	chr2:30370270-30370271	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
46	rs550248074	chr2:30370272-30370273	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
47	rs570641041	chr2:30370295-30370296	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
48	rs532954812	chr2:30370324-30370325	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs546877240	chr2:30370432-30370433	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs12987354	chr2:30370478-30370479	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:66)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Cancer	16751803	CNVD
Neuroblastoma	16790693	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	17393978	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Bladder cancer	21909424	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Autism	22495311	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Medulloblastoma	16968546	CNVD
Leukemia	18628472	CNVD
Autism	19521722	CNVD
Autism	18522746	CNVD
Breast cancer	21364760	CNVD
Wilms tumour	21544195	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	18927303	CNVD
Hepatocellular carcinoma	16750200	CNVD
Lung cancer	16740712	CNVD
Hereditary gingival fibromatosis	19633868	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21785460	CNVD
Breast cancer	21509527	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Tetralogy of Fallot	22912587	CNVD
Myelofibrosis	22110671	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:558 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:30368400-30369000	Enhancers	Primary monocytes fromperipheralblood	blood
2	chr2:30368600-30369000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
3	chr2:30368600-30369000	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
4	chr2:30368600-30369000	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
5	chr2:30368600-30369000	Enhancers	Brain Substantia Nigra	brain
6	chr2:30368600-30369000	Enhancers	Duodenum Smooth Muscle	Duodenum
7	chr2:30368600-30369000	Enhancers	Fetal Intestine Small	intestine
8	chr2:30368600-30369000	Flanking Active TSS	Pancreatic Islets	Pancreatic Islet
9	chr2:30368600-30369000	Enhancers	Fetal Muscle Leg	muscle
10	chr2:30368600-30369000	Enhancers	Fetal Stomach	stomach
11	chr2:30368600-30369200	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
12	chr2:30368600-30369200	Flanking Active TSS	Primary T cells from cord blood	blood
13	chr2:30368600-30369200	Flanking Active TSS	Primary T cells fromperipheralblood	blood
14	chr2:30368600-30369200	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
15	chr2:30368600-30369200	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
16	chr2:30368600-30369200	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
17	chr2:30368600-30369200	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
18	chr2:30368600-30369200	Flanking Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
19	chr2:30368600-30369200	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
20	chr2:30368600-30369200	Flanking Active TSS	HMEC	breast
21	chr2:30368600-30369200	Flanking Active TSS	NHEK	skin
22	chr2:30368600-30369400	Flanking Active TSS	Primary hematopoietic stem cells	blood
23	chr2:30368600-30369400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
24	chr2:30368600-30369400	Flanking Active TSS	GM12878-XiMat	blood
25	chr2:30368600-30370800	Active TSS	Fetal Brain Female	brain
26	chr2:30368600-30371200	Active TSS	Brain Angular Gyrus	brain
27	chr2:30368800-30369000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
28	chr2:30368800-30369000	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
29	chr2:30368800-30369000	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
30	chr2:30368800-30369000	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
31	chr2:30368800-30369000	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
32	chr2:30368800-30369000	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
33	chr2:30368800-30369000	Enhancers	Muscle Satellite Cultured Cells	--
34	chr2:30368800-30369000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
35	chr2:30368800-30369000	Enhancers	Liver	Liver
36	chr2:30368800-30369000	Enhancers	Brain Germinal Matrix	brain
37	chr2:30368800-30369000	Flanking Active TSS	Fetal Brain Male	brain
38	chr2:30368800-30369000	Enhancers	Fetal Heart	heart
39	chr2:30368800-30369000	Enhancers	Fetal Kidney	kidney
40	chr2:30368800-30369000	Enhancers	Fetal Lung	lung
41	chr2:30368800-30369000	Enhancers	Placenta	Placenta
42	chr2:30368800-30369000	Enhancers	Stomach Mucosa	stomach
43	chr2:30368800-30369000	Active TSS	Stomach Smooth Muscle	stomach
44	chr2:30368800-30369000	Flanking Bivalent TSS/Enh	A549	lung
45	chr2:30368800-30369000	Enhancers	HSMM	muscle
46	chr2:30368800-30369000	Active TSS	HSMMtube	muscle
47	chr2:30368800-30369000	Flanking Bivalent TSS/Enh	NH-A	brain
48	chr2:30368800-30369200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
49	chr2:30368800-30369200	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
50	chr2:30368800-30369200	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links